河南医学研究2024,Vol.33Issue(13) :2493-2496.DOI:10.3969/j.issn.1004-437X.2024.13.048

肝硬化患者肌少症的管理研究进展

Research Progress in the Management of Sarcopenia in Patients with Liver Cirrhosis

时莉莉 郝娜 杨嫚 薛文俊
河南医学研究2024,Vol.33Issue(13) :2493-2496.DOI:10.3969/j.issn.1004-437X.2024.13.048

肝硬化患者肌少症的管理研究进展

Research Progress in the Management of Sarcopenia in Patients with Liver Cirrhosis

时莉莉 1郝娜 2杨嫚 1薛文俊1
扫码查看

作者信息

  • 1. 河南省人民医院消化内科,河南郑州 450008
  • 2. 郑州大学第二附属医院消化内科,河南郑州 450014
  • 折叠

摘要

肝硬化常常导致机体能量代谢、激素分泌和免疫稳态发生异常,这些代谢过程的紊乱会导致肌少症或病理性肌肉萎缩.肌少症是肝硬化患者常见并发症之一,常常预示患者预后不佳,包括住院时间、感染性并发症和死亡率等.准确评估、早期营养支持和及时治疗对于肝硬化并肌少症患者具有重要意义.本文综述了肝硬化患者肌少症的发生机制、肌少症评估工具和干预措施.

Abstract

Cirrhosis predisposes to abnormalities in energy,hormonal,and immunological homeostasis.Disturbances in these metabolic processes create susceptibility to sarcopenia or pathological muscle wasting.Sarcopenia is prevalent in cirrhosis.Its presence portends significant adverse outcomes including the length of hospital stay,infectious complications,and mortality.This highlights the importance of identification of at-risk individuals with early nutritional,therapeutic and physical therapy intervention.This manuscript summarizes literature relevant to sarcopenia in cirrhosis,describes mechanism,evaluation methods and intervention measures for sarcopenia.

关键词

肝硬化/肌少症/护理/综述

Key words

cirrhosis of the liver/sarcopenia/nursing/review

引用本文复制引用

出版年

2024
河南医学研究
河南省医学科学院

河南医学研究

影响因子:0.979
ISSN:1004-437X
参考文献量2
段落导航相关论文